Radiation doses from digital breast tomosynthesis is comparable to and could be lower than conventional two-view full-field digital mammography.
Radiation doses from digital breast tomosynthesis is comparable to and could be lower than conventional two-view full-field digital mammography, show findings of a study published in the April issue of Radiology.
Researchers from Emory University School of Medicine in Atlanta, Ga., compared dose levels of digital breast tomosynthesis (DBT) and full-field digital mammography (FFDM) by using compressible water-oil mixture breast phantoms of varying sizes to determine how much radiation dose would be used for varying sizes and glandular compositions of breasts.
When comparing doses with the “average” breast (compressed thickness of 5 cm, 50 percent glandular fraction), a DBT acquisition resulted in 1.30 mGy, only an 8 percent higher mean glandular dose than the FFDM acquisition of 1.20 mGy. For a thicker breast sample (6.0 cm and 14.3 percent glandular fraction), a DBT acquisition was 2.12 mGy, which was 83 percent higher than an FFDM acquisition of 1.16 mGy.
RELATED: Practices Adjust Workflow IT for Tomosynthesis Adoption
Although the thicker breast had a higher dose, the researchers pointed out that this was still lower than the 3 mGy limit for a single-view conventional study, which is set by the Mammography Quality Standards Act.
Potentially, screening DBT could reduce the recall rate, reducing the number of repeat scans, which reduces women’s overall radiation dose rate.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
Moving Beyond Mammography for Screening and Staging of Invasive Lobular Carcinoma
February 16th 2024For women with dense breasts, only 25 percent of breast radiologists are confident in the use of mammography for diagnosing invasive lobular carcinoma, according to newly published survey results from the Society of Breast Imaging.